Top Institutions in Precision Oncology and Next-Generation Sequencing (NGS) Workflow Optimization
Institutions leading in this area typically combine cutting-edge genomic research with clinical oncology programs and have established high-throughput molecular diagnostics laboratories. They often pioneer workflow automation, validate NGS assays for clinical use, and publish extensively on precision oncology and laboratory process optimization.
-
#100
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC is a global leader in precision oncology with a robust molecular pathology program that integrates NGS into clinical workflows. Their research includes optimizing NGS assays and automating workflows to improve turnaround times and scalability.
Key Differentiators
- Precision Oncology
- Molecular Diagnostics
- Next-Generation Sequencing
-
#92
Dana-Farber Cancer Institute
Boston, MA
Dana-Farber combines comprehensive cancer care with advanced genomic testing, focusing on streamlining NGS workflows to support high-volume precision oncology testing and clinical trials.
Key Differentiators
- Precision Oncology
- Genomic Medicine
- Molecular Pathology
-
#89
MD Anderson Cancer Center
Houston, TX
MD Anderson has a large molecular diagnostics lab with expertise in NGS assay development and workflow optimization, emphasizing automation and cost-effectiveness in precision oncology testing.
Key Differentiators
- Precision Oncology
- Molecular Diagnostics
- Cancer Genomics
-
#85
Broad Institute of MIT and Harvard
Cambridge, MA
The Broad Institute is a leader in genomic technology innovation, developing NGS platforms and bioinformatics tools that enhance efficiency and accuracy in oncology sequencing workflows.
Key Differentiators
- Genomics Research
- Precision Medicine
- NGS Technology Development
-
#80
Johns Hopkins Medicine
Baltimore, MD
Johns Hopkins integrates clinical oncology with molecular diagnostics, emphasizing workflow improvements and automation in NGS to support precision oncology and personalized treatment strategies.
Key Differentiators
- Molecular Pathology
- Precision Oncology
- Clinical Genomics
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
References
- S Stone et al., “Results of a time and motion study of two next-generation sequencing workflows in a routine oncology biomarker profiling setting,” Poster G066, presented at the Association of Molecular Pathology Annual Meeting (2025).
